MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: SkinBioTherapeutics loss widens as underperforms in US

ALN

SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says pretax loss widens to £1.2 million in six months to December 31, from £628,241 a year earlier. US market penetration with its only product launched in October 2021, AxisBiotix-Ps, for treating Psoriasis, was slower than expected, company adds. Revenue for the half comes in at £21,949, against none a year earlier. For the financial year ending in June, the company expects revenue materially below expectations, it warns.

Current stock price: 37.27 pence, down 18% on Tuesday

12-month change: down 21%

Copyright 2022 Alliance News Limited. All Rights Reserved.